A study comparing sequential biopsies suggests that repeating whole-genome sequencing is not necessary in most cases. Researchers found that 99% of actionable mutations detected by the initial round of sequencing were present in later biopsies, although repeating the test could be beneficial for patients receiving certain therapies.

You do not currently have access to this content.